SEC Form 4 · accession 0001437749-16-043049
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Wrighton-Smith
Officer — Chief Executive Officer · Director
Period of report
Dec 5, 2016
Accepted (ET)
Dec 7, 2016 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 5, 2016 | M | 1,140 | $0.81 | A | 444,454 | D | |
| Ordinary Shares | Dec 5, 2016 | S | 1,140 | $15.00 | D | 443,314 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F3 | $0.81 | Dec 5, 2016 | M | 1,140 | D | — | Feb 17, 2020 | Ordinary Shares | 1,140 | 108,490 | D |
Explanation of responses
- F1The original exercise price of these options was priced in GBP at GBP0.51 and converted to US$ at an exchange rate of US$1.58823=1GBP.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended.
- F3Exercise from an option granted February 28, 2013, which became fully vested on April 1, 2014.